First-line immune checkpoint inhibitors + chemotherapy in Taiwanese patients with extensive-stage small cell lung cancer
{{output}}
Background: Immune checkpoint inhibitors (ICIs) have demonstrated survival benefits when combined with platinum and etoposide (EP) in first-line (1L) treatment for extensive-stage small cell lung cancer (ES-SCLC). We investigated... ...
